Features

Thumbnail

Reported in 2018 by anesthesiologists at the University of Florida College of Medicine in Gainesville, the case suggested a message to TAVR operators: “Vigilance and a high degree of suspicion” are critical for avoiding the potentially severe hemodynamic consequences of HCM associated with aortic stenosis, the authors asserted (J Med Case Rep 2018;18;12[1]:372).

Thumbnail

At the American College of Radiology’s 2019 meeting last May, speaker after speaker stepped up to the open microphone in the ballroom of a Washington, D.C., hotel to vent their displeasure with the American Board of Radiology (ABR) and its maintenance of certification (MOC) program.

Thumbnail

Ahead of print in Radiology Business Journal: As private medical practices continue feeling the squeeze of consolidation across U.S. healthcare, many radiology groups are considering acquisition offers from physician practice management companies (PPMCs).

Thumbnail

Until recently, cardiologists’ eyes tended to glaze over at the mention of using 3D printing in their practices. Most believed the costs would be too high for routine use, that the applications and the price tag were better suited to academic applications.

Thumbnail

To get the operational perspective, CVB hosted a roundtable discussion with service line leaders about the opportunities and challenges they encounter around data.
 

Thumbnail

Experienced dyad and triad partners share tips for setting the stage for success and putting the brakes on mistakes.

Thumbnail

As many as 700 hearts from donors with hepatitis C are discarded each year in the U.S. New research suggests at least some of these organs may be suitable for transplant.

Thumbnail

Following data supporting their use for heart failure and type 2 diabetes, will sodium-glucose cotransporter 2 inhibitors find a spot in the heart failure armamentarium?

Thumbnail

Clinical trials presented at ACC.19 flipped the script on TAVR vs. SAVR. 

Thumbnail

The global market for transcatheter treatment of the mitral and aortic valves is expected to increase from $4 billion to $8 billion in the next five years, but barriers exist. 

Thumbnail

While the clinical case for cardiac PET is compelling, it also has to be feasible from a financial and logistical standpoint.

Thumbnail

Atrial fibrillation patients with coronary artery disease pose a delicate balancing act for physicians. A growing awareness of bleeding vs. ischemic risks could soon lead to a steadier therapeutic response.

Around the web

An oral version of the popular GLP-1 drug was associated with multiple benefits, including considerable improvements in BMI and waist circumference. Previous research found that it reduces certain heart risks in patients with type 2 diabetes.

Screening TAVR patients for CAS may provide significant value, according to a new meta-analysis of 15 different studies.

A Class 2 recall has been issued for the systems due to a software glitch that could impact treatment accuracy.